bookmark

Cancer Drug to Be Provided To Limited Number of Patients - New York Times


Description

ImClone Systems and Bristol-Myers Squibb said yesterday that they would begin to provide their cancer drug, Erbitux, to a limited number of colorectal cancer patients who have exhausted other treatment options.

Preview

Tags

Users

  • @hansonflemser

Comments and Reviews